Unilever (UL) 6-K 26 Jul 23 2023 Q2 Current report (foreign) Financial data

Cover page

Cover page	6 Months Ended
	Jun. 30, 2023
Cover [Abstract]
Document Type	6-K
Entity Registrant Name	UNILEVER PLC
Amendment Flag	false
Entity Central Index Key	0000217410
Current Fiscal Year End Date	--12-31
Document Period End Date	Jun. 30, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2

Consolidated income statement

Consolidated income statement - EUR (€) € in Millions	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Profit or loss [abstract]
Turnover	€ 30,428	€ 29,623
Operating profit	5,516	4,500
Net finance costs	(259)	(227)
Pensions and similar obligations	50	22
Finance income	208	105
Finance costs	(517)	(354)
Net monetary gain/(loss) arising from hyperinflationary economies	(98)	(38)
Share of net profit/(loss) of joint ventures and associates	118	97
Other income/(loss) from non-current investments and associates	(10)	27
Profit before taxation	5,267	4,359
Taxation	(1,385)	(1,143)
Net profit	3,882	3,216
Attributable to:
Non-controlling interests	334	311
Shareholders’ equity	€ 3,548	€ 2,905
Earnings per share
Basic earnings per share (in euros per share)	€ 1.41	€ 1.14
Diluted earnings per share (in euros per share)	€ 1.40	€ 1.13

Consolidated statement of compr

Consolidated statement of comprehensive income - EUR (€) € in Millions	6 Months Ended
	Jun. 30, 2023		Jun. 30, 2022
Statement of comprehensive income [abstract]
Net profit	€ 3,882		€ 3,216
Items that will not be reclassified to profit or loss, net of tax:
Gains/(losses) on equity instruments measured at fair value through other comprehensive income	(34)		52
Remeasurement of defined benefit pension plans	(47)		1,463
Items that may be reclassified subsequently to profit or loss, net of tax:
Gains/(losses) on cash flow hedges	(22)		51
Currency retranslation gains/(losses)	(555)	[1]	1,309
Total comprehensive income	3,224		6,091
Attributable to:
Non-controlling interests	284		384
Shareholders’ equity	€ 2,940		€ 5,707
[1]Includes a hyperinflation adjustment of €247 million in relation to Argentina and Turkey.

Consolidated statement of chang

Consolidated statement of changes in equity - EUR (€) € in Millions		Total	Total	Called up share capital	Share premium account	Unification reserve	Other reserves	Retained profit	Non- controlling interest
Equity at beginning of period at Dec. 31, 2021		€ 19,746	€ 17,107	€ 92	€ 52,844	€ (73,364)	€ (9,210)	€ 46,745	€ 2,639
Profit or loss for the period		3,216	2,905					2,905	311
Gains/(losses) on:
Equity instruments		52	44				44		8
Cash flow hedges		51	48				48		3
Remeasurement of defined benefit pension plans		1,463	1,462					1,462	1
Currency retranslation gains/(losses)		1,309	1,248				1,240	8	61
Total comprehensive income		6,091	5,707				1,332	4,375	384
Dividends on ordinary capital		(2,195)	(2,195)					(2,195)
Repurchase of shares	[1]	(648)	(648)				(648)
Movements in treasury shares	[2]	(8)	(8)				99	(107)
Share-based payment credit	[3]	93	93					93
Dividends paid to non-controlling interests		(309)							(309)
Hedging gain/(loss) transferred to non-financial assets		(136)	(133)				(133)		(3)
Other movements in equity	[4]	232	218				2	216	14
Equity at end of period at Jun. 30, 2022		22,866	20,141	92	52,844	(73,364)	(8,558)	49,127	2,725
Equity at beginning of period at Dec. 31, 2022		21,701	19,021	92	52,844	(73,364)	(10,804)	50,253	2,680
Profit or loss for the period		3,882	3,548					3,548	334
Gains/(losses) on:
Equity instruments		(34)	(33)				(33)		(1)
Cash flow hedges		(22)	(22)				(22)
Remeasurement of defined benefit pension plans		(47)	(48)					(48)	1
Currency retranslation gains/(losses)	[5]	(555)	(505)				(736)	231	(50)
Total comprehensive income		3,224	2,940				(791)	3,731	284
Dividends on ordinary capital		(2,172)	(2,172)					(2,172)
Repurchase of shares	[1]	(753)	(753)				(753)
Movements in treasury shares	[2]	1	1				69	(68)
Share-based payment credit	[3]	159	159					159
Dividends paid to non-controlling interests		(276)							(276)
Hedging gain/(loss) transferred to non-financial assets		78	78				78
Other movements in equity		(41)	(17)				5	(22)	(24)
Equity at end of period at Jun. 30, 2023		€ 21,921	€ 19,257	€ 92	€ 52,844	€ (73,364)	€ (12,196)	€ 51,881	€ 2,664
[1]Repurchase of shares reflects the cost of acquiring ordinary shares as part of the share buyback program announced on 10 February 2022.[2]Includes purchases and sales of treasury shares, other than the share buyback programme and the transfer from treasury shares to retained profit of share-settled schemes arising from prior years and differences between purchase and grant price of share awards.[3]The share-based payment credit relates to the non-cash charge recorded against operating profit in respect of the fair value of share options and awards granted to employees.[4]Includes a hyperinflation adjustment of €235 million in relation to Argentina.[5]Includes a hyperinflation adjustment of €247 million in relation to Argentina and Turkey.

Consolidated statement of cha_2

Consolidated statement of changes in equity (Parenthetical) - EUR (€) € in Millions	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Statement of changes in equity [abstract]
Hyperinflation adjustment	€ 247	€ 235

Consolidated balance sheet

Consolidated balance sheet - EUR (€) € in Millions	Jun. 30, 2023	Dec. 31, 2022	Jun. 30, 2022
Non-current assets
Goodwill	€ 21,299	€ 21,609	€ 21,571
Intangible assets	18,664	18,880	18,935
Property, plant and equipment	10,590	10,770	10,733
Pension asset for funded schemes in surplus	4,244	4,260	6,581
Deferred tax assets	1,084	1,049	1,559
Financial assets	1,220	1,154	1,286
Other non-current assets	952	942	1,023
Total non-current assets	58,053	58,664	61,688
Current assets
Inventories	5,668	5,931	5,893
Trade and other current receivables	8,046	7,056	7,309
Current tax assets	254	381	324
Cash and cash equivalents	4,994	4,326	5,411
Other financial assets	1,376	1,435	1,435
Assets held for sale	18	28	2,832
Total current assets	20,356	19,157	23,204
Total assets	78,409	77,821	84,892
Current liabilities
Financial liabilities	6,715	5,775	9,032
Trade payables and other current liabilities	17,367	18,023	17,151
Current tax liabilities	891	877	1,327
Provisions	634	748	640
Liabilities held for sale	0	4	788
Total current liabilities	25,607	25,427	28,938
Non-current liabilities
Financial liabilities	23,993	23,713	24,929
Non-current tax liabilities	280	94	163
Pensions and post-retirement healthcare liabilities:
Funded schemes in deficit	431	613	362
Unfunded schemes	1,040	1,078	1,189
Provisions	547	550	621
Deferred tax liabilities	4,410	4,375	5,523
Other non-current liabilities	180	270	301
Total non current liabilities	30,881	30,693	33,088
Total liabilities	56,488	56,120	62,026
Equity
Shareholders’ equity	19,257	19,021	20,141
Non-controlling interests	2,664	2,680	2,725
Total equity	21,921	21,701	22,866
Total liabilities and equity	€ 78,409	€ 77,821	€ 84,892

Consolidated cash flow statemen

Consolidated cash flow statement - EUR (€) € in Millions	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash flows from (used in) operating activities [abstract]
Net profit	€ 3,882	€ 3,216
Taxation	1,385	1,143
Share of net (profit)/loss of joint ventures/associates and other (income)/loss from non-current investments and associates	(108)	(124)
Net monetary (gain)/loss arising from hyperinflationary economies	98	38
Net finance costs	259	227
Operating profit	5,516	4,500
Depreciation, amortisation and impairment	754	842
Changes in working capital	(1,331)	(1,116)
Pensions and similar obligations less payments	(103)	(49)
Provisions less payments	(122)	135
Elimination of (profits)/losses on disposals	(507)	(28)
Non-cash charge for share-based compensation	159	93
Other adjustments	11	(33)
Cash flow from operating activities	4,377	4,344
Income tax paid	(1,011)	(1,295)
Net cash flow from operating activities	3,366	3,049
Cash flows from (used in) investing activities [abstract]
Interest received	139	106
Net capital expenditure	(548)	(593)
Acquisitions and disposals	352	2
Other investing activities	(143)	53
Net cash flow (used in)/from investing activities	(200)	(432)
Cash flows from (used in) financing activities [abstract]
Dividends paid on ordinary share capital	(2,202)	(2,176)
Interest paid	(503)	(323)
Change in financial liabilities	1,230	2,500
Repurchase of shares	(753)	(648)
Other financing activities	(261)	(277)
Net cash flow (used in)/from financing activities	(2,489)	(924)
Net increase/(decrease) in cash and cash equivalents	677	1,693
Cash and cash equivalents at the beginning of the period	4,225	3,387
Effect of foreign exchange rate changes	(32)	194
Cash and cash equivalents at the end of the period	€ 4,870	€ 5,274

Accounting information and poli

Accounting information and policies	6 Months Ended
	Jun. 30, 2023
Disclosure Of Summary Of Significant Accounting Policies [Abstract]
Accounting information and policies	1. Accounting information and policies These condensed consolidated financial statements are prepared in accordance with IAS 34 'Interim Financial Reporting' as issued by the International Accounting Standards Board (IASB) and as adopted for use in the UK. As required by the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the condensed consolidated financial statements have been prepared applying the accounting policies and presentation that were applied in the preparation of the Group’s published consolidated financial statements for the year ended 31 December 2022. In preparing these condensed consolidated financial statements, judgements and estimates that affect the application of accounting policies used by management have remained consistent with those applied in the consolidated financial statements for the year ended 31 December 2022. Management have produced forecasts which have been modelled for different plausible scenarios. These scenarios confirm the Group is able to generate profits and cash in the year ended 31 December 2023 and beyond. As a result, the Directors have a reasonable expectation that the Group has adequate resources to meet its obligations as they fall due for a period of at least 12 months from the date of signing these condensed consolidated financial statements. Accordingly, they continue to adopt the going concern basis in preparing the half year condensed consolidated financial statements. The condensed consolidated financial statements are shown at current exchange rates with year-on-year changes shown to facilitate comparison. The consolidated income statement on page 15, the consolidated statement of comprehensive income on page 15, the consolidated statement of changes in equity on page 16 and the consolidated cash flow statement on page 18 are translated at exchange rates current in each period. The consolidated balance sheet on page 17 is translated at period-end rates of exchange. The condensed consolidated financial statements attached do not constitute the full financial statements within the meaning of section 434 of the UK Companies Act 2006. The comparative figures for the financial year ended 31 December 2022 are not Unilever PLC’s statutory accounts for that financial year. The annual financial statements of the Group are prepared in accordance with international financial reporting standards (IFRS) as issued by the International Accounting Standards Board (IASB) and UK adopted international accounting standards and in accordance with the requirements of the UK Companies Act 2006. New accounting standards As of 1 January 2023, IFRS 17 ‘Insurance Contracts’ has been adopted by the Group. The standard introduces a new model for accounting for insurance contracts. We have reviewed existing arrangements and concluded that IFRS 17 does not impact the condensed consolidated financial statements. As of 23 May 2023, amendments to IAS 12 'Income Taxes' came into effect relating to International Tax Reform – Pillar Two Model Rules, which were endorsed by the UK Endorsement Board on 19 July, whereby an entity shall disclose qualitative and quantitative information about its exposure to Pillar Two income taxes at the end of the reporting period. The amendments provide a temporary mandatory exemption from deferred tax accounting for the top-up tax, which is effective immediately. The expected impact of this amendment will be disclosed within the 2023 Annual Report. All other new standards or amendments issued by the IASB and UK Endorsement Board that are effective or not yet effective, are either not applicable or not material to the Group.

Significant items within the in

Significant items within the income statement	6 Months Ended
	Jun. 30, 2023
Disclosure Of Non-Underlying Items [Abstract]
Significant items within the income statement	2. Significant items within the income statement Non-underlying items These include non-underlying items within operating profit and non-underlying items not in operating profit but within net profit: • Non-underlying items within operating profit are gains or losses on business disposals, acquisition and disposal related costs, restructuring costs, impairments and other items within operating profit classified here due to their nature and frequency. • Non-underlying items not in operating profit but within net profit are net monetary gain/(loss) arising from hyperinflationary economies and significant and unusual items in net finance cost, share of profit/(loss) of joint ventures and associates and taxation. Restructuring costs are charges associated with activities planned by management that significantly change either the scope of the business or the manner in which it is conducted. € million First Half 2023 2022 Acquisition and disposal-related credits/(costs) (a) (52) (87) Gain/(loss) on disposal of group companies (b) 528 21 Restructuring costs (c) (184) (359) Impairments (d) (1) (4) Other (e) 17 (115) Non-underlying items within operating profit before tax 308 (544) Tax on non-underlying items within operating profit (111) 102 Non-underlying items within operating profit after tax 197 (442) Interest related to the UK tax audit of intangible income and centralised services (5) – Net monetary gain/(loss) arising from hyperinflationary economies (98) (38) Non-underlying items not in operating profit but within net profit before tax (103) (38) Tax impact of non-underlying items not in operating profit but within net profit: Taxes related to separation of Ekaterra (6) (39) Taxes related to the UK tax audit of intangible income and centralised services 1 – Hyperinflation adjustment for Argentina and Turkey deferred tax (75) (24) Non-underlying items not in operating profit but within net profit after tax (183) (101) Non-underlying items after tax (f) 14 (543) Attributable to: Non-controlling interests – (8) Shareholders’ equity 14 (535) (a) 2023 includes a charge of €4 million (2022: €56 million) relating to the disposal of ekaterra and other acquisition and disposal activities. (b) 2023 includes a gain of €497 million related to the disposal of Suave business in North America. (c) Restructuring costs are comprised of organisational change programmes including Compass and various technology and supply chain optimisation projects. (d) Impairments include write downs of leased land and building assets. (e) 2022 comprised of €40 million of asset write-downs relating to our businesses in Russia and Ukraine and €75 million relating to legal provisions for ongoing competition investigations. (f) Non-underlying items after tax is calculated as non-underlying items within operating profit after tax plus non-underlying items not in operating profit but within net profit after tax.

Segment information - Business

Segment information - Business Groups	6 Months Ended
	Jun. 30, 2023
Disclosure of operating segments [abstract]
Segment information - Business Groups	3. Segment information - Business Groups Second Quarter Beauty & Wellbeing Personal Care Home Care Nutrition Ice Cream Total Turnover (€ million) 2022 2,999 3,420 3,092 3,596 2,703 15,810 2023 3,143 3,519 3,057 3,260 2,760 15,739 Change (%) 4.8 2.9 (1.1) (9.3) 2.1 (0.4) First Half Beauty & Wellbeing Personal Care Home Care Nutrition Ice Cream Total Turnover (€ million) 2022 5,731 6,445 6,024 7,107 4,316 29,623 2023 6,225 6,911 6,205 6,601 4,486 30,428 Change (%) 8.6 7.3 3.0 (7.1) 3.9 2.7 Operating profit (€ million) 2022 995 1,174 609 1,124 598 4,500 2023 1,237 1,691 731 1,213 644 5,516 Underlying operating profit (€ million) 2022 1,083 1,295 723 1,253 690 5,044 2023 1,179 1,381 763 1,214 671 5,208 Turnover growth is made up of distinct individual growth components namely underlying sales, currency impact, acquisitions and disposals. Turnover growth is arrived at by multiplying these individual components on a compounded basis as there is a currency impact on each of the other components. Accordingly, turnover growth is more than just the sum of the individual components. Underlying operating profit represents our measure of segment profit or loss as it is the primary measure used for the purpose of making decisions about allocating resources and assessing performance of segments. Underlying operating margin is calculated as underlying operating profit divided by turnover.

Segment information - Geographi

Segment information - Geographical area	6 Months Ended
	Jun. 30, 2023
Disclosure of operating segments [abstract]
Segment information - Geographical area	4. Segment information - Geographical area Second Quarter Asia Pacific Africa The Americas Europe Total Turnover (€ million) 2022 7,061 5,414 3,335 15,810 2023 6,699 5,700 3,340 15,739 Change (%) (5.1) 5.3 0.1 (0.4) First Half Asia Pacific Africa The Americas Europe Total Turnover (€ million) 2022 13,701 9,941 5,982 29,623 2023 13,421 10,956 6,051 30,428 Change (%) (2.0) 10.2 1.2 2.7

Taxation

Taxation	6 Months Ended
	Jun. 30, 2023
Income taxes paid (refund) [abstract]
Taxation	5. Taxation The effective tax rate for the first half is 26.9% compared with 26.8% in 2022. The tax rate is calculated by dividing the tax charge by pre-tax profit excluding the contribution of joint ventures and associates. Tax effects of components of other comprehensive income were as follows: First half 2023 2022 € million Before tax Tax (charge)/credit After tax Before tax Tax (charge)/credit After tax Gains/(losses) on: Equity instruments at fair value through other comprehensive income (34) – (34) 49 3 52 Cash flow hedges (20) (2) (22) 26 25 51 Remeasurements of defined benefit pension plans (90) 43 (47) 2,037 (574) 1,463 Currency retranslation gains/(losses) (535) (20) (555) 1,317 (8) 1,309 Other comprehensive income (679) 21 (658) 3,429 (554) 2,875

Earnings per share

Earnings per share	6 Months Ended
	Jun. 30, 2023
Earnings per share [abstract]
Earnings per share	6. Earnings per share The earnings per share calculations are based on the average number of share units representing the ordinary shares of PLC in issue during the period, less the average number of shares held as treasury shares. In calculating diluted earnings per share and underlying earnings per share, a number of adjustments are made to the number of shares, principally the exercise of share plans by employees. Earnings per share for total operations for the twelve months were calculated as follows: First Half 2023 2022 EPS – Basic Net profit attributable to shareholders’ equity (€ million) 3,548 2,905 Average number of shares (millions of share units) 2,523.9 2,557.3 EPS – basic (€) 1.41 1.14 EPS – Diluted Net profit attributable to shareholders’ equity (€ million) 3,548 2,905 Adjusted average number of shares (millions of share units) 2,536.8 2,566.2 EPS – diluted (€) 1.40 1.13 Underlying EPS Net profit attributable to shareholders’ equity (€ million) 3,548 2,905 Post-tax impact of non-underlying items attributable to shareholders’ equity (see note 2) (14) 535 Underlying profit attributable to shareholders’ equity 3,534 3,440 Adjusted average number of shares (millions of share units) 2,536.8 2,566.2 Underlying EPS – diluted (€) 1.39 1.34 Notes to the condensed consolidated financial statements (unaudited) 6. Earnings per share (continued) In calculating underlying earnings per share, net profit attributable to shareholders’ equity is adjusted to eliminate the post-tax impact of non-underlying items. During the period the following movements in shares have taken place: Millions Number of shares at 31 December 2022 (net of treasury shares) 2,529.0 Net movements in shares under incentive schemes 1.5 Shares repurchased under the share buyback programme (15.5) Number of shares at 30 June 2023 2,515.0

Acquisitions and disposals

Acquisitions and disposals	6 Months Ended
	Jun. 30, 2023
Disclosure of detailed information about business combination [abstract]
Acquisitions and disposals	7. Acquisitions and disposals In the first half of 2023, the Group completed the following business acquisitions and disposals: Deal completion date Acquired/disposed business 10 January 2023 Acquired 51% of Zywie Ventures Private Limited (“OZiva”), a leading plant-based, and clean-label consumer wellness brand focused on the need spaces such as Lifestyle Protein, Hair & Beauty Supplements and Women’s health. 1 May 2023 Sold Suave brand in North America to Yellow Wood Partners LLC. The Suave beauty and personal care brand includes hair care, skin care, skin cleansing and deodorant products. On 1 May 2023, Unilever sold the North America Suave business to Yellow Wood Partners LLC for €592 million consideration. Profit on this disposal was €497 million, recognised as a non-underlying item (see note 2).

Share-buy back

Share-buy back	6 Months Ended
	Jun. 30, 2023
Share Buyback [Abstract]
Share-buy back	8. Share-buy back On 10 February 2022, we announced a share buyback programme of up to €3 billion to be completed over 2022 and 2023. During the first half of 2023, the Group repurchased 15,552,684 ordinary shares which are held by Unilever as treasury shares. Consideration paid for the repurchase of shares including transaction costs was €753 million which is recorded within other reserves.

Financial instruments

Financial instruments	6 Months Ended
	Jun. 30, 2023
Disclosure of detailed information about financial instruments [abstract]
Financial instruments	9. Financial instruments The Group’s Treasury function aims to protect the Group’s financial investments, while maximising returns. The fair value of financial assets is the same as the carrying amount for 2023 and 2022. The Group’s cash resources and 30 June 2023 31 December 2022 30 June 2022 Current Non-current Total Current Non-current Total Current Non-current Total Cash and cash equivalents Cash at bank and in hand 2,790 – 2,790 2,553 – 2,553 2,730 – 2,730 Short-term deposits (a) 1,804 – 1,804 1,743 – 1,743 2,481 – 2,481 Other cash equivalents (b) 400 – 400 30 – 30 200 – 200 4,994 – 4,994 4,326 – 4,326 5,411 – 5,411 Other financial assets Financial assets at amortised cost (c) 727 352 1,079 772 232 1,004 756 220 976 Financial assets at fair value through other comprehensive income (d) – 438 438 – 407 407 – 547 547 Financial assets at fair value through profit or loss: Derivatives 36 31 67 238 51 289 264 60 324 Other (e) 613 399 1,012 425 464 889 415 459 874 1,376 1,220 2,596 1,435 1,154 2,589 1,435 1,286 2,721 Total financial assets (f) 6,370 1,220 7,590 5,761 1,154 6,915 6,846 1,286 8,132 (a) Short-term deposits typically have maturity of up to 3 months. (b) Other cash equivalents include investments in overnight funds and treasury bills. (c) Current financial assets at amortised cost include short term deposits with banks with maturities longer than three months excluding deposits which are part of a recognised cash management process and loans to joint venture entities. Non-current financial assets at amortised cost include judicial deposits of €228 million (31 December 2022: €199 million; 30 June 2022: €195 million). (d) Included within non-current financial assets at fair value through other comprehensive income are equity investments. (e) Other financial assets at fair value through profit or loss include money market funds, marketable securities, other capital market instruments (f) Financial assets exclude trade and other current receivables. The Group is exposed to the risks of changes in fair value of its financial assets and liabilities. The following tables summarise the fair values and carrying amounts of financial instruments and the fair value calculations by category. € million Fair value Carrying amount As at 30 June 2023 As at 31 December 2022 As at 30 June 2022 As at 30 June 2023 As at 31 December 2022 As at 30 June 2022 Financial assets Cash and cash equivalents 4,994 4,326 5,411 4,994 4,326 5,411 Financial assets at amortised cost 1,079 1,004 976 1,079 1,004 976 Financial assets at fair value through other comprehensive income 438 407 547 438 407 547 Financial assets at fair value through profit and loss: Derivatives 67 289 324 67 289 324 Other 1,012 889 874 1,012 889 874 7,590 6,915 8,132 7,590 6,915 8,132 Financial liabilities Bank loans and overdrafts (606) (519) (540) (606) (519) (540) Bonds and other loans (26,265) (25,136) (30,089) (27,599) (26,512) (31,007) Lease liabilities (1,428) (1,408) (1,585) (1,428) (1,408) (1,585) Derivatives (618) (631) (548) (618) (631) (548) Other financial liabilities (457) (418) (281) (457) (418) (281) (29,374) (28,112) (33,043) (30,708) (29,488) (33,961) Notes to the condensed consolidated financial statements (unaudited) 9. Financial instruments (continued) € million As at 30 June 2023 As at 31 December 2022 As at 30 June 2022 Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 Assets at fair value Financial assets at fair value through other comprehensive income 14 3 421 5 3 399 11 3 533 Financial assets at fair value through profit or loss: Derivatives (a) – 142 – – 378 – – 505 – Other 613 – 399 428 – 461 420 – 454 Liabilities at fair value Derivatives (b) – (718) – – (784) – – (729) – Contingent consideration – – (123) – – (164) – – (175) (a) Includes €75 million (31 December 2022: €89 million; 30 June 2022: €181 million) derivatives, reported within trade receivables, that hedge trading activities. (b) Includes €(100) million (31 December 2022: €(153) million; 30 June 2022: €(181) million) derivatives, reported within trade creditors, that hedge trading activities. There were no significant changes in classification of fair value of financial assets and financial liabilities since 31 December 2022. There were also no significant movements between the fair value hierarchy classifications since 31 December 2022. The fair value of trade receivables and payables is considered to be equal to the carrying amount of these items due to their short-term nature. The fair value of financial assets and financial liabilities (excluding listed bonds) is considered to be same as the carrying amount for 2023 and 2022. Calculation of fair values The fair values of the financial assets and liabilities are defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Methods and assumptions used to estimate the fair values are consistent with those used in the year ended 31 December 2022.

Dividends

Dividends	6 Months Ended
	Jun. 30, 2023
Dividends [Abstract]
Dividends	10. Dividends The Board has declared a quarterly interim dividend for Q2 2023 of £0.3700 per Unilever PLC ordinary share or €0.4268 per Unilever PLC ordinary share at the applicable exchange rate issued by WM/Reuters on 21 July 2023. The following amounts will be paid in respect of this quarterly interim dividend on the relevant payment date: Per Unilever PLC ordinary share (traded on the London Stock Exchange): £0.3700 Per Unilever PLC ordinary share (traded on Euronext in Amsterdam): €0.4268 Per Unilever PLC American Depositary Receipt: US$0.4746 The euro and US dollar amounts above have been determined using the applicable exchange rates issued by WM/Reuters on 21 July 2023. US dollar cheques for the quarterly interim dividend will be mailed on 31 August 2023 to holders of record at the close of business on 4 August 2023. The quarterly dividend calendar for the remainder of 2023 will be as follows: Announcement Date Ex-Dividend Date Record Date Payment Date Q2 2023 Dividend 25 July 2023 03 August 2023 04 August 2023 31 August 2023 Q3 2023 Dividend 26 October 2023 16 November 2023 17 November 2023 08 December 2023

Events after the balance sheet

Events after the balance sheet date	6 Months Ended
	Jun. 30, 2023
Disclosure of non-adjusting events after reporting period [abstract]
Events after the balance sheet date	11. Events after the balance sheet date

Accounting information and po_2

Accounting information and policies (Policies)	6 Months Ended
	Jun. 30, 2023
Disclosure Of Summary Of Significant Accounting Policies [Abstract]
Basis of preparation	These condensed consolidated financial statements are prepared in accordance with IAS 34 'Interim Financial Reporting' as issued by the International Accounting Standards Board (IASB) and as adopted for use in the UK. As required by the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the condensed consolidated financial statements have been prepared applying the accounting policies and presentation that were applied in the preparation of the Group’s published consolidated financial statements for the year ended 31 December 2022. In preparing these condensed consolidated financial statements, judgements and estimates that affect the application of accounting policies used by management have remained consistent with those applied in the consolidated financial statements for the year ended 31 December 2022. Management have produced forecasts which have been modelled for different plausible scenarios. These scenarios confirm the Group is able to generate profits and cash in the year ended 31 December 2023 and beyond. As a result, the Directors have a reasonable expectation that the Group has adequate resources to meet its obligations as they fall due for a period of at least 12 months from the date of signing these condensed consolidated financial statements. Accordingly, they continue to adopt the going concern basis in preparing the half year condensed consolidated financial statements. The condensed consolidated financial statements are shown at current exchange rates with year-on-year changes shown to facilitate comparison. The consolidated income statement on page 15, the consolidated statement of comprehensive income on page 15, the consolidated statement of changes in equity on page 16 and the consolidated cash flow statement on page 18 are translated at exchange rates current in each period. The consolidated balance sheet on page 17 is translated at period-end rates of exchange.
New acounting standards	New accounting standards As of 1 January 2023, IFRS 17 ‘Insurance Contracts’ has been adopted by the Group. The standard introduces a new model for accounting for insurance contracts. We have reviewed existing arrangements and concluded that IFRS 17 does not impact the condensed consolidated financial statements. As of 23 May 2023, amendments to IAS 12 'Income Taxes' came into effect relating to International Tax Reform – Pillar Two Model Rules, which were endorsed by the UK Endorsement Board on 19 July, whereby an entity shall disclose qualitative and quantitative information about its exposure to Pillar Two income taxes at the end of the reporting period. The amendments provide a temporary mandatory exemption from deferred tax accounting for the top-up tax, which is effective immediately. The expected impact of this amendment will be disclosed within the 2023 Annual Report. All other new standards or amendments issued by the IASB and UK Endorsement Board that are effective or not yet effective, are either not applicable or not material to the Group.

Significant items within the _2

Significant items within the income statement (Tables)	6 Months Ended
	Jun. 30, 2023
Disclosure Of Non-Underlying Items [Abstract]
Summary of Non-Underlying Items	€ million First Half 2023 2022 Acquisition and disposal-related credits/(costs) (a) (52) (87) Gain/(loss) on disposal of group companies (b) 528 21 Restructuring costs (c) (184) (359) Impairments (d) (1) (4) Other (e) 17 (115) Non-underlying items within operating profit before tax 308 (544) Tax on non-underlying items within operating profit (111) 102 Non-underlying items within operating profit after tax 197 (442) Interest related to the UK tax audit of intangible income and centralised services (5) – Net monetary gain/(loss) arising from hyperinflationary economies (98) (38) Non-underlying items not in operating profit but within net profit before tax (103) (38) Tax impact of non-underlying items not in operating profit but within net profit: Taxes related to separation of Ekaterra (6) (39) Taxes related to the UK tax audit of intangible income and centralised services 1 – Hyperinflation adjustment for Argentina and Turkey deferred tax (75) (24) Non-underlying items not in operating profit but within net profit after tax (183) (101) Non-underlying items after tax (f) 14 (543) Attributable to: Non-controlling interests – (8) Shareholders’ equity 14 (535) (a) 2023 includes a charge of €4 million (2022: €56 million) relating to the disposal of ekaterra and other acquisition and disposal activities. (b) 2023 includes a gain of €497 million related to the disposal of Suave business in North America. (c) Restructuring costs are comprised of organisational change programmes including Compass and various technology and supply chain optimisation projects. (d) Impairments include write downs of leased land and building assets. (e) 2022 comprised of €40 million of asset write-downs relating to our businesses in Russia and Ukraine and €75 million relating to legal provisions for ongoing competition investigations. (f) Non-underlying items after tax is calculated as non-underlying items within operating profit after tax plus non-underlying items not in operating profit but within net profit after tax.

Segment information - Busines_2

Segment information - Business Groups (Tables)	6 Months Ended
	Jun. 30, 2023
Disclosure of operating segments [abstract]
Summary of Operating Results by Reportable Segments	Second Quarter Beauty & Wellbeing Personal Care Home Care Nutrition Ice Cream Total Turnover (€ million) 2022 2,999 3,420 3,092 3,596 2,703 15,810 2023 3,143 3,519 3,057 3,260 2,760 15,739 Change (%) 4.8 2.9 (1.1) (9.3) 2.1 (0.4) First Half Beauty & Wellbeing Personal Care Home Care Nutrition Ice Cream Total Turnover (€ million) 2022 5,731 6,445 6,024 7,107 4,316 29,623 2023 6,225 6,911 6,205 6,601 4,486 30,428 Change (%) 8.6 7.3 3.0 (7.1) 3.9 2.7 Operating profit (€ million) 2022 995 1,174 609 1,124 598 4,500 2023 1,237 1,691 731 1,213 644 5,516 Underlying operating profit (€ million) 2022 1,083 1,295 723 1,253 690 5,044 2023 1,179 1,381 763 1,214 671 5,208

Segment information - Geograp_2

Segment information - Geographical area (Tables)	6 Months Ended
	Jun. 30, 2023
Disclosure of operating segments [abstract]
Summary of Operating Results by Geographical Areas	Second Quarter Asia Pacific Africa The Americas Europe Total Turnover (€ million) 2022 7,061 5,414 3,335 15,810 2023 6,699 5,700 3,340 15,739 Change (%) (5.1) 5.3 0.1 (0.4) First Half Asia Pacific Africa The Americas Europe Total Turnover (€ million) 2022 13,701 9,941 5,982 29,623 2023 13,421 10,956 6,051 30,428 Change (%) (2.0) 10.2 1.2 2.7

Taxation (Tables)

Taxation (Tables)	6 Months Ended
	Jun. 30, 2023
Income taxes paid (refund) [abstract]
Summary of Tax Effects of Components of Other Comprehensive Income	Tax effects of components of other comprehensive income were as follows: First half 2023 2022 € million Before tax Tax (charge)/credit After tax Before tax Tax (charge)/credit After tax Gains/(losses) on: Equity instruments at fair value through other comprehensive income (34) – (34) 49 3 52 Cash flow hedges (20) (2) (22) 26 25 51 Remeasurements of defined benefit pension plans (90) 43 (47) 2,037 (574) 1,463 Currency retranslation gains/(losses) (535) (20) (555) 1,317 (8) 1,309 Other comprehensive income (679) 21 (658) 3,429 (554) 2,875

Earnings per share (Tables)

Earnings per share (Tables)	6 Months Ended
	Jun. 30, 2023
Earnings per share [abstract]
Schedule of Computation of Earnings Per Share and Summary of Movements in Shares	Earnings per share for total operations for the twelve months were calculated as follows: First Half 2023 2022 EPS – Basic Net profit attributable to shareholders’ equity (€ million) 3,548 2,905 Average number of shares (millions of share units) 2,523.9 2,557.3 EPS – basic (€) 1.41 1.14 EPS – Diluted Net profit attributable to shareholders’ equity (€ million) 3,548 2,905 Adjusted average number of shares (millions of share units) 2,536.8 2,566.2 EPS – diluted (€) 1.40 1.13 Underlying EPS Net profit attributable to shareholders’ equity (€ million) 3,548 2,905 Post-tax impact of non-underlying items attributable to shareholders’ equity (see note 2) (14) 535 Underlying profit attributable to shareholders’ equity 3,534 3,440 Adjusted average number of shares (millions of share units) 2,536.8 2,566.2 Underlying EPS – diluted (€) 1.39 1.34 During the period the following movements in shares have taken place: Millions Number of shares at 31 December 2022 (net of treasury shares) 2,529.0 Net movements in shares under incentive schemes 1.5 Shares repurchased under the share buyback programme (15.5) Number of shares at 30 June 2023 2,515.0

Acquisitions and disposals (Tab

Acquisitions and disposals (Tables)	6 Months Ended
	Jun. 30, 2023
Disclosure of detailed information about business combination [abstract]
Disclosure of Detailed Information about Deal Completion and Acquired Business	In the first half of 2023, the Group completed the following business acquisitions and disposals: Deal completion date Acquired/disposed business 10 January 2023 Acquired 51% of Zywie Ventures Private Limited (“OZiva”), a leading plant-based, and clean-label consumer wellness brand focused on the need spaces such as Lifestyle Protein, Hair & Beauty Supplements and Women’s health. 1 May 2023 Sold Suave brand in North America to Yellow Wood Partners LLC. The Suave beauty and personal care brand includes hair care, skin care, skin cleansing and deodorant products.

Financial instruments (Tables)

Financial instruments (Tables)	6 Months Ended
	Jun. 30, 2023
Disclosure of detailed information about financial instruments [abstract]
Schedule of Cash Resources and Other Financial Assets	The Group’s Treasury function aims to protect the Group’s financial investments, while maximising returns. The fair value of financial assets is the same as the carrying amount for 2023 and 2022. The Group’s cash resources and 30 June 2023 31 December 2022 30 June 2022 Current Non-current Total Current Non-current Total Current Non-current Total Cash and cash equivalents Cash at bank and in hand 2,790 – 2,790 2,553 – 2,553 2,730 – 2,730 Short-term deposits (a) 1,804 – 1,804 1,743 – 1,743 2,481 – 2,481 Other cash equivalents (b) 400 – 400 30 – 30 200 – 200 4,994 – 4,994 4,326 – 4,326 5,411 – 5,411 Other financial assets Financial assets at amortised cost (c) 727 352 1,079 772 232 1,004 756 220 976 Financial assets at fair value through other comprehensive income (d) – 438 438 – 407 407 – 547 547 Financial assets at fair value through profit or loss: Derivatives 36 31 67 238 51 289 264 60 324 Other (e) 613 399 1,012 425 464 889 415 459 874 1,376 1,220 2,596 1,435 1,154 2,589 1,435 1,286 2,721 Total financial assets (f) 6,370 1,220 7,590 5,761 1,154 6,915 6,846 1,286 8,132 (a) Short-term deposits typically have maturity of up to 3 months. (b) Other cash equivalents include investments in overnight funds and treasury bills. (c) Current financial assets at amortised cost include short term deposits with banks with maturities longer than three months excluding deposits which are part of a recognised cash management process and loans to joint venture entities. Non-current financial assets at amortised cost include judicial deposits of €228 million (31 December 2022: €199 million; 30 June 2022: €195 million). (d) Included within non-current financial assets at fair value through other comprehensive income are equity investments. (e) Other financial assets at fair value through profit or loss include money market funds, marketable securities, other capital market instruments (f) Financial assets exclude trade and other current receivables.
Summary of Fair Values of Financial Assets and Financial Liabilities	The following tables summarise the fair values and carrying amounts of financial instruments and the fair value calculations by category. € million Fair value Carrying amount As at 30 June 2023 As at 31 December 2022 As at 30 June 2022 As at 30 June 2023 As at 31 December 2022 As at 30 June 2022 Financial assets Cash and cash equivalents 4,994 4,326 5,411 4,994 4,326 5,411 Financial assets at amortised cost 1,079 1,004 976 1,079 1,004 976 Financial assets at fair value through other comprehensive income 438 407 547 438 407 547 Financial assets at fair value through profit and loss: Derivatives 67 289 324 67 289 324 Other 1,012 889 874 1,012 889 874 7,590 6,915 8,132 7,590 6,915 8,132 Financial liabilities Bank loans and overdrafts (606) (519) (540) (606) (519) (540) Bonds and other loans (26,265) (25,136) (30,089) (27,599) (26,512) (31,007) Lease liabilities (1,428) (1,408) (1,585) (1,428) (1,408) (1,585) Derivatives (618) (631) (548) (618) (631) (548) Other financial liabilities (457) (418) (281) (457) (418) (281) (29,374) (28,112) (33,043) (30,708) (29,488) (33,961)
Summary of Assets and Liabilities Carried at Fair Value, Classification of Fair Value Calculations by Category	€ million As at 30 June 2023 As at 31 December 2022 As at 30 June 2022 Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 Assets at fair value Financial assets at fair value through other comprehensive income 14 3 421 5 3 399 11 3 533 Financial assets at fair value through profit or loss: Derivatives (a) – 142 – – 378 – – 505 – Other 613 – 399 428 – 461 420 – 454 Liabilities at fair value Derivatives (b) – (718) – – (784) – – (729) – Contingent consideration – – (123) – – (164) – – (175) (a) Includes €75 million (31 December 2022: €89 million; 30 June 2022: €181 million) derivatives, reported within trade receivables, that hedge trading activities. (b) Includes €(100) million (31 December 2022: €(153) million; 30 June 2022: €(181) million) derivatives, reported within trade creditors, that hedge trading activities.

Dividends (Tables)

Dividends (Tables)	6 Months Ended
	Jun. 30, 2023
Dividends [Abstract]
Summary of Dividends on Ordinary Capital	The following amounts will be paid in respect of this quarterly interim dividend on the relevant payment date: Per Unilever PLC ordinary share (traded on the London Stock Exchange): £0.3700 Per Unilever PLC ordinary share (traded on Euronext in Amsterdam): €0.4268 Per Unilever PLC American Depositary Receipt: US$0.4746
Summary of Quarterly Dividend Calendar	The quarterly dividend calendar for the remainder of 2023 will be as follows: Announcement Date Ex-Dividend Date Record Date Payment Date Q2 2023 Dividend 25 July 2023 03 August 2023 04 August 2023 31 August 2023 Q3 2023 Dividend 26 October 2023 16 November 2023 17 November 2023 08 December 2023

Significant items within the _3

Significant items within the income statement (Details) - EUR (€) € in Millions		6 Months Ended
	May 01, 2023	Jun. 30, 2023	Jun. 30, 2022
Disclosure of attribution of expenses by nature to their function [line items]
Acquisition and disposal-related credits/(costs)		€ (52)	€ (87)
Gain/(loss) on disposal of group companies		528	21
Restructuring costs		(184)	(359)
Impairments		(1)	(4)
Other		17	(115)
Non-underlying items within operating profit before tax		308	(544)
Tax on non-underlying items within operating profit		(111)	102
Non-underlying items within operating profit after tax		197	(442)
Interest related to the UK tax audit of intangible income and centralised services		(5)	0
Net monetary gain/(loss) arising from hyperinflationary economies		(98)	(38)
Non-underlying items not in operating profit but within net profit before tax		(103)	(38)
Tax impact of non-underlying items not in operating profit but within net profit:
Taxes related to separation of Ekaterra		(6)	(39)
Taxes related to the UK tax audit of intangible income and centralised services		1	0
Hyperinflation adjustment for Argentina and Turkey deferred tax		(75)	(24)
Non-underlying items not in operating profit but within net profit after tax		(183)	(101)
Non-underlying items after tax		14	(543)
Attributable to:
Non-controlling interests		0	(8)
Shareholders’ equity		14	(535)
Assets write-downs			40
Ekaterra
Disclosure of attribution of expenses by nature to their function [line items]
Acquisition and disposal-related credits/(costs)		(4)	(56)
Suave
Attributable to:
Gain on disposal of Suave	€ 497	€ 497
Legal proceedings provision
Attributable to:
Legal provision			€ 75

Segment information - Busines_3

Segment information - Business Groups (Details) - EUR (€) € in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Disclosure of operating segments [line items]
Turnover (€ million)	€ 15,739	€ 15,810	€ 30,428	€ 29,623
Change (%)	(0.40%)		2.70%
Operating profit (€ million)			€ 5,516	4,500
Underlying operating profit (€ million)			5,208	5,044
Beauty & Wellbeing
Disclosure of operating segments [line items]
Turnover (€ million)	€ 3,143	2,999	€ 6,225	5,731
Change (%)	4.80%		8.60%
Operating profit (€ million)			€ 1,237	995
Underlying operating profit (€ million)			1,179	1,083
Personal Care
Disclosure of operating segments [line items]
Turnover (€ million)	€ 3,519	3,420	€ 6,911	6,445
Change (%)	2.90%		7.30%
Operating profit (€ million)			€ 1,691	1,174
Underlying operating profit (€ million)			1,381	1,295
Home Care
Disclosure of operating segments [line items]
Turnover (€ million)	€ 3,057	3,092	€ 6,205	6,024
Change (%)	(1.10%)		3%
Operating profit (€ million)			€ 731	609
Underlying operating profit (€ million)			763	723
Nutrition
Disclosure of operating segments [line items]
Turnover (€ million)	€ 3,260	3,596	€ 6,601	7,107
Change (%)	(9.30%)		(7.10%)
Operating profit (€ million)			€ 1,213	1,124
Underlying operating profit (€ million)			1,214	1,253
Ice Cream
Disclosure of operating segments [line items]
Turnover (€ million)	€ 2,760	€ 2,703	€ 4,486	4,316
Change (%)	2.10%		3.90%
Operating profit (€ million)			€ 644	598
Underlying operating profit (€ million)			€ 671	€ 690

Segment information - Geograp_3

Segment information - Geographical area (Details) - EUR (€) € in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Disclosure of operating segments [line items]
Turnover (€ million)	€ 15,739	€ 15,810	€ 30,428	€ 29,623
Change (%)	(0.40%)		2.70%
Asia Pacific Africa
Disclosure of operating segments [line items]
Turnover (€ million)	€ 6,699	7,061	€ 13,421	13,701
Change (%)	(5.10%)		(2.00%)
The Americas
Disclosure of operating segments [line items]
Turnover (€ million)	€ 5,700	5,414	€ 10,956	9,941
Change (%)	5.30%		10.20%
Europe
Disclosure of operating segments [line items]
Turnover (€ million)	€ 3,340	€ 3,335	€ 6,051	€ 5,982
Change (%)	0.10%		1.20%

Taxation - Narrative (Details)

Taxation - Narrative (Details)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Income taxes paid (refund) [abstract]
Average effective tax rate (in percent)	26.90%	26.80%

Taxation - Summary of Tax Effec

Taxation - Summary of Tax Effects of Components of Other Comprehensive Income (Details) - EUR (€) € in Millions	6 Months Ended
	Jun. 30, 2023		Jun. 30, 2022
Before tax
Equity instruments at fair value through other comprehensive income	€ (34)		€ 49
Cash flow hedges	(20)		26
Remeasurements of defined benefit pension plans	(90)		2,037
Currency retranslation gains/(losses)	(535)		1,317
Other comprehensive income	(679)		3,429
Tax (charge)/credit
Equity instruments at fair value through other comprehensive income	0		3
Cash flow hedges	(2)		25
Remeasurements of defined benefit pension plans	43		(574)
Currency retranslation gains/(losses)	(20)		(8)
Other comprehensive income	21		(554)
After tax
Equity instruments at fair value through other comprehensive income	(34)		52
Cash flow hedges	(22)		51
Remeasurements of defined benefit pension plans	(47)		1,463
Currency retranslation gains/(losses)	(555)	[1]	1,309
Other comprehensive income	€ (658)		€ 2,875
[1]Includes a hyperinflation adjustment of €247 million in relation to Argentina and Turkey.

Earnings per share - Schedule o

Earnings per share - Schedule of Computation of Earnings Per Share (Details) - EUR (€) € / shares in Units, € in Millions, shares in Millions	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
EPS – Basic
Net profit attributable to shareholders’ equity (€ million)	€ 3,548	€ 2,905
Average number of shares (in millions of shares)	2,523.9	2,557.3
EPS - basic (in euros per share)	€ 1.41	€ 1.14
EPS – Diluted
Net profit attributable to shareholders’ equity (€ million)	€ 3,548	€ 2,905
Diluted average number of shares (in millions of shares)	2,536.8	2,566.2
EPS - diluted (in euros per share)	€ 1.40	€ 1.13
Underlying EPS
Net profit attributable to shareholders’ equity (€ million)	€ 3,548	€ 2,905
Post-tax impact of non-underlying items attributable to shareholders’ equity (see note 2)	(14)	535
Underlying profit attributable to shareholders’ equity	€ 3,534	€ 3,440
Diluted average number of shares (in millions of shares)	2,536.8	2,566.2
Underlying EPS – diluted (in euros per share)	€ 1.39	€ 1.34

Earnings per share - Summary of

Earnings per share - Summary of Movements in Shares (Details) shares in Millions	6 Months Ended
	Jun. 30, 2023 shares
Reconciliation of number of shares outstanding [abstract]
Number of shares outstanding at beginning of period (in shares)	2,529
Net movements in shares under incentive schemes (in shares)	1.5
Shares repurchased under the share buyback programme (in shares)	(15.5)
Number of shares outstanding at end of period (in shares)	2,515

Acquisitions and disposals - Di

Acquisitions and disposals - Disclosure of Detailed Information about Deal Completion and Acquired Business (Details)	Jan. 10, 2023
Zywie Ventures Private Limited
Disclosure of detailed information about business combination [line items]
Percentage of voting equity interests acquired	51%

Acquisitions and disposals - Na

Acquisitions and disposals - Narrative (Details) - Suave - EUR (€) € in Millions		6 Months Ended
	May 01, 2023	Jun. 30, 2023
Disclosure of analysis of single amount of discontinued operations [line items]
Consideration received	€ 592
Gain on disposal of Suave	€ 497	€ 497

Share-buy back (Details)

Share-buy back (Details) - EUR (€) € in Millions			6 Months Ended
		Feb. 10, 2022	Jun. 30, 2023	Jun. 30, 2022
Disclosure of reserves within equity [line items]
Number of shares acquired (in shares)			15,552,684
Reourchase of shares	[1]		€ 753	€ 648
Other reserves
Disclosure of reserves within equity [line items]
Reourchase of shares	[1]		€ 753	€ 648
Top of range
Disclosure of reserves within equity [line items]
Share buyback program, authorized amount		€ 3,000
[1]Repurchase of shares reflects the cost of acquiring ordinary shares as part of the share buyback program announced on 10 February 2022.

Financial instruments - Schedul

Financial instruments - Schedule of Cash Resources and Other Financial Assets (Details) - EUR (€) € in Millions	Jun. 30, 2023	Dec. 31, 2022	Jun. 30, 2022
Cash and cash equivalents, current
Cash at bank and in hand	€ 2,790	€ 2,553	€ 2,730
Short-term deposits	1,804	1,743	2,481
Other cash equivalents	400	30	200
Cash and cash equivalents	4,994	4,326	5,411
Other financial assets, current
Financial assets at amortised cost	727	772	756
Financial assets at fair value through other comprehensive income	0	0	0
Other financial assets	1,376	1,435	1,435
Current financial assets	6,370	5,761	6,846
Cash and cash equivalents, non-current
Cash at bank and in hand	0	0	0
Short-term deposits	0	0	0
Other cash equivalents	0	0	0
Cash and cash equivalents	0	0	0
Other financial assets, non-current
Financial assets at amortised cost	352	232	220
Financial assets at fair value through other comprehensive income	438	407	547
Other financial assets	1,220	1,154	1,286
Non-current financial assets	1,220	1,154	1,286
Cash and cash equivalents, total
Cash at bank and in hand	2,790	2,553	2,730
Short-term deposits	1,804	1,743	2,481
Other cash equivalents	400	30	200
Cash and cash equivalents	4,994	4,326	5,411
Other financial assets, total
Financial assets at amortised cost	1,079	1,004	976
Financial assets at fair value through other comprehensive income	438	407	547
Other financial assets	2,596	2,589	2,721
Financial assets	7,590	6,915	8,132
Financial assets at amortised cost	352	232	220
Judicial deposits
Other financial assets, non-current
Financial assets at amortised cost	228	199	195
Other financial assets, total
Financial assets at amortised cost	228	199	195
Derivatives
Other financial assets, current
Financial assets at fair value through profit or loss	36	238	264
Other financial assets, non-current
Financial assets at fair value through profit or loss	31	51	60
Other financial assets, total
Financial assets at fair value through profit or loss	67	289	324
Other
Other financial assets, current
Financial assets at fair value through profit or loss	613	425	415
Other financial assets, non-current
Financial assets at fair value through profit or loss	399	464	459
Other financial assets, total
Financial assets at fair value through profit or loss	€ 1,012	€ 889	€ 874

Financial instruments - Summary

Financial instruments - Summary of Fair Values of Financial Assets and Financial Liabilities (Details) - EUR (€) € in Millions	Jun. 30, 2023	Dec. 31, 2022	Jun. 30, 2022
Financial assets
Cash and cash equivalents	€ 4,994	€ 4,326	€ 5,411
Financial assets at amortised cost	1,079	1,004	976
Financial assets at fair value through other comprehensive income	438	407	547
Financial assets	7,590	6,915	8,132
Derivatives
Financial assets
Financial assets at fair value through profit or loss	67	289	324
Other
Financial assets
Financial assets at fair value through profit or loss	1,012	889	874
Fair value
Financial assets
Cash and cash equivalents	4,994	4,326	5,411
Financial assets at amortised cost	1,079	1,004	976
Financial assets at fair value through other comprehensive income	438	407	547
Financial assets	7,590	6,915	8,132
Financial liabilities
Bank loans and overdrafts	(606)	(519)	(540)
Bonds and other loans	(26,265)	(25,136)	(30,089)
Lease liabilities	(1,428)	(1,408)	(1,585)
Derivatives	(618)	(631)	(548)
Other financial liabilities	(457)	(418)	(281)
Financial liabilities	(29,374)	(28,112)	(33,043)
Fair value | Derivatives
Financial assets
Financial assets at fair value through profit or loss	67	289	324
Fair value | Other
Financial assets
Financial assets at fair value through profit or loss	1,012	889	874
Carrying amount
Financial assets
Cash and cash equivalents	4,994	4,326	5,411
Financial assets at amortised cost	1,079	1,004	976
Financial assets at fair value through other comprehensive income	438	407	547
Financial assets	7,590	6,915	8,132
Financial liabilities
Bank loans and overdrafts	(606)	(519)	(540)
Bonds and other loans	(27,599)	(26,512)	(31,007)
Lease liabilities	(1,428)	(1,408)	(1,585)
Derivatives	(618)	(631)	(548)
Other financial liabilities	(457)	(418)	(281)
Financial liabilities	(30,708)	(29,488)	(33,961)
Carrying amount | Derivatives
Financial assets
Financial assets at fair value through profit or loss	67	289	324
Carrying amount | Other
Financial assets
Financial assets at fair value through profit or loss	€ 1,012	€ 889	€ 874

Financial instruments - Summa_2

Financial instruments - Summary of Assets and Liabilities Carried at Fair Value, Classification of Fair Value Calculations by Category (Details) - EUR (€) € in Millions	Jun. 30, 2023	Dec. 31, 2022	Jun. 30, 2022
Assets at fair value
Financial assets at fair value through other comprehensive income	€ 438	€ 407	€ 547
Derivatives
Financial assets at fair value through profit and loss:
Other	67	289	324
Other
Financial assets at fair value through profit and loss:
Other	1,012	889	874
Fair value
Assets at fair value
Financial assets at fair value through other comprehensive income	438	407	547
Liabilities at fair value
Derivatives financial assets, reported within trade receivables	75	89	181
Derivatives financial liabilities, reported within trade creditors	(100)	(153)	(181)
Fair value | Derivatives
Financial assets at fair value through profit and loss:
Other	67	289	324
Fair value | Other
Financial assets at fair value through profit and loss:
Other	1,012	889	874
Fair value | Level 1
Assets at fair value
Financial assets at fair value through other comprehensive income	14	5	11
Fair value | Level 1 | Derivatives
Liabilities at fair value
Derivatives	0	0	0
Fair value | Level 1 | Financial liabilities at fair value
Liabilities at fair value
Contingent consideration	0	0	0
Fair value | Level 1 | Derivatives
Financial assets at fair value through profit and loss:
Derivatives	0	0	0
Fair value | Level 1 | Other
Financial assets at fair value through profit and loss:
Other	613	428	420
Fair value | Level 2
Assets at fair value
Financial assets at fair value through other comprehensive income	3	3	3
Fair value | Level 2 | Derivatives
Liabilities at fair value
Derivatives	(718)	(784)	(729)
Fair value | Level 2 | Financial liabilities at fair value
Liabilities at fair value
Contingent consideration	0	0	0
Fair value | Level 2 | Derivatives
Financial assets at fair value through profit and loss:
Derivatives	142	378	505
Fair value | Level 2 | Other
Financial assets at fair value through profit and loss:
Other	0	0	0
Fair value | Level 3
Assets at fair value
Financial assets at fair value through other comprehensive income	421	399	533
Fair value | Level 3 | Derivatives
Liabilities at fair value
Derivatives	0	0	0
Fair value | Level 3 | Financial liabilities at fair value
Liabilities at fair value
Contingent consideration	(123)	(164)	(175)
Fair value | Level 3 | Derivatives
Financial assets at fair value through profit and loss:
Derivatives	0	0	0
Fair value | Level 3 | Other
Financial assets at fair value through profit and loss:
Other	€ 399	€ 461	€ 454

Dividends - Summary of Dividend

Dividends - Summary of Dividends on Ordinary Capital (Details) - 3 months ended Jun. 30, 2023 - Unilever PLC	£ / shares	€ / shares	$ / shares
Disclosure Of Dividends [Line Items]
Dividend per share (in pound, euro and dollar per share) | (per share)	£ 0.3700	€ 0.4268
Per Unilever PLC ordinary share | Traded on the London Stock Exchange
Disclosure Of Dividends [Line Items]
Dividend per share (in pound, euro and dollar per share) | £ / shares	£ 0.3700
Per Unilever PLC ordinary share | Traded on Euronext in Amsterdam
Disclosure Of Dividends [Line Items]
Dividend per share (in pound, euro and dollar per share) | € / shares		€ 0.4268
Per Unilever PLC American Depositary Receipt
Disclosure Of Dividends [Line Items]
Dividend per share (in pound, euro and dollar per share) | $ / shares			$ 0.4746

Dividends - Narrative (Details)

Dividends - Narrative (Details) - 3 months ended Jun. 30, 2023	£ / shares	€ / shares
Unilever PLC
Disclosure Of Dividends [Line Items]
Dividend per share (in pound, euro and dollar per share) | (per share)	£ 0.3700	€ 0.4268